Literature DB >> 3707645

Ibopamine, an orally active dopamine-like drug: metabolism and pharmacokinetics in rats.

F Pocchiari, R Pataccini, P Castelnovo, A Longo, C Casagrande.   

Abstract

Ibopamine (SB-7505), the 3,4-diisobutyrylester of N-methyldopamine (epinine), was rapidly hydrolyzed to epinine by plasma esterases of rat as well as of other animal species and man. Ibopamine was rapidly and extensively metabolized after oral administration to rat. Plasma levels of free epinine peaked at 30-60 min from the administration; conjugated epinine was present in larger amount, with a maximum at 3 h. Both free and conjugated epinine were still detectable at 6 h, but not at 24 h. Epinine 4-O-glucuronide, 4-hydroxy-3-methoxyphenylacetic acid and 3,4-dihydroxyphenylacetic acid appeared as main urinary metabolites; epinine 3-O-sulphate, epinine 3-O-methylether and its glucuronide, and trace amounts of epinine 4-O-sulphate were also detected.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3707645

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  3 in total

Review 1.  Ibopamine. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.

Authors:  J M Henwood; P A Todd
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

2.  Investigation of a possible pharmacokinetic interaction between ibopamine and isosorbide-5-mononitrate.

Authors:  R A Lefebvre; G De Wilde; M T Rosseel; D Duprez; J De Sutter; F Pocchiari
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

3.  Ibopamine (SK&F 100168) pharmacokinetics in relation to the timing of meals.

Authors:  S C Scott; J Locke-Haydon; N S Pready; N P Buller; R J Cregeen
Journal:  Br J Clin Pharmacol       Date:  1987-05       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.